14 mayo 2015
A single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation, new research has found. The switch, scientists say, allows for the elimination of the donor cells that cause graft versus host disease but leave behind the component that fights viral infection.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/L8XRzls-0ho/150514102803.htm
